Effect of amygdaloid kindling on rat striatal dopamine D1- and D2-receptors. 1994

R Allin, and M Mintz, and V Russell, and A Engelbrecht, and M Lamm, and W Daniels, and G van der Spuy, and A Jaffer, and L Kellaway, and J Taljaard
Department of Chemical Pathology, University of Stellenbosch, Tygerberg, R.S.A.

The effect of kindling on dopaminergic (DA) neurotransmission was assessed by measuring dopamine D1- and D2-receptor binding in the dorsal and ventral striatum of rats either 2 hours (short-term) or 3-4 weeks (long-term) after the last kindled seizure. Kindling did not have any significant long-term effect on DA D2-receptor Kd or Bmax values in the dorsal or ventral striatum or on DA D1-receptor parameters in the dorsal striatum. The short-term effect of kindled seizures was to abolish the asymmetry in DA D2-receptor density observed in the dorsal striatum of control rats. DA D1-receptor density was also increased in the dorsal striatum contralateral to the kindled amygdala of short-term rats. The short-term effects support the notion that limbic seizures can modify the lateral imbalance of DA activity in the striatum.

UI MeSH Term Description Entries
D007696 Kindling, Neurologic The repeated weak excitation of brain structures, that progressively increases sensitivity to the same stimulation. Over time, this can lower the threshold required to trigger seizures. Kindlings, Neurologic,Neurologic Kindling,Neurologic Kindlings
D007839 Functional Laterality Behavioral manifestations of cerebral dominance in which there is preferential use and superior functioning of either the left or the right side, as in the preferred use of the right hand or right foot. Ambidexterity,Behavioral Laterality,Handedness,Laterality of Motor Control,Mirror Writing,Laterality, Behavioral,Laterality, Functional,Mirror Writings,Motor Control Laterality,Writing, Mirror,Writings, Mirror
D008297 Male Males
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine
D000679 Amygdala Almond-shaped group of basal nuclei anterior to the INFERIOR HORN OF THE LATERAL VENTRICLE of the TEMPORAL LOBE. The amygdala is part of the limbic system. Amygdaloid Body,Amygdaloid Nuclear Complex,Amygdaloid Nucleus,Archistriatum,Corpus Amygdaloideum,Intercalated Amygdaloid Nuclei,Massa Intercalata,Nucleus Amygdalae,Amygdalae, Nucleus,Amygdaloid Bodies,Amygdaloid Nuclear Complices,Amygdaloid Nuclei, Intercalated,Amygdaloid Nucleus, Intercalated,Amygdaloideum, Corpus,Amygdaloideums, Corpus,Archistriatums,Complex, Amygdaloid Nuclear,Complices, Amygdaloid Nuclear,Corpus Amygdaloideums,Intercalata, Massa,Intercalatas, Massa,Intercalated Amygdaloid Nucleus,Massa Intercalatas,Nuclear Complex, Amygdaloid,Nuclear Complices, Amygdaloid,Nuclei, Intercalated Amygdaloid,Nucleus, Amygdaloid,Nucleus, Intercalated Amygdaloid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012399 Rotation Motion of an object in which either one or more points on a line are fixed. It is also the motion of a particle about a fixed point. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Clinorotation,Clinorotations,Rotations
D017447 Receptors, Dopamine D1 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D1-class receptor genes lack INTRONS, and the receptors stimulate ADENYLYL CYCLASES. Dopamine D1 Receptors,Dopamine-D1 Receptor,D1 Receptors, Dopamine,Dopamine D1 Receptor,Receptor, Dopamine-D1

Related Publications

R Allin, and M Mintz, and V Russell, and A Engelbrecht, and M Lamm, and W Daniels, and G van der Spuy, and A Jaffer, and L Kellaway, and J Taljaard
February 1992, The Journal of pharmacy and pharmacology,
R Allin, and M Mintz, and V Russell, and A Engelbrecht, and M Lamm, and W Daniels, and G van der Spuy, and A Jaffer, and L Kellaway, and J Taljaard
June 1988, Journal of neurochemistry,
R Allin, and M Mintz, and V Russell, and A Engelbrecht, and M Lamm, and W Daniels, and G van der Spuy, and A Jaffer, and L Kellaway, and J Taljaard
March 2003, Synapse (New York, N.Y.),
R Allin, and M Mintz, and V Russell, and A Engelbrecht, and M Lamm, and W Daniels, and G van der Spuy, and A Jaffer, and L Kellaway, and J Taljaard
January 2003, Pain,
R Allin, and M Mintz, and V Russell, and A Engelbrecht, and M Lamm, and W Daniels, and G van der Spuy, and A Jaffer, and L Kellaway, and J Taljaard
November 2000, Naunyn-Schmiedeberg's archives of pharmacology,
R Allin, and M Mintz, and V Russell, and A Engelbrecht, and M Lamm, and W Daniels, and G van der Spuy, and A Jaffer, and L Kellaway, and J Taljaard
January 1997, Brain research bulletin,
R Allin, and M Mintz, and V Russell, and A Engelbrecht, and M Lamm, and W Daniels, and G van der Spuy, and A Jaffer, and L Kellaway, and J Taljaard
November 2011, Synapse (New York, N.Y.),
R Allin, and M Mintz, and V Russell, and A Engelbrecht, and M Lamm, and W Daniels, and G van der Spuy, and A Jaffer, and L Kellaway, and J Taljaard
July 1990, European journal of pharmacology,
R Allin, and M Mintz, and V Russell, and A Engelbrecht, and M Lamm, and W Daniels, and G van der Spuy, and A Jaffer, and L Kellaway, and J Taljaard
January 1992, Brain research. Molecular brain research,
R Allin, and M Mintz, and V Russell, and A Engelbrecht, and M Lamm, and W Daniels, and G van der Spuy, and A Jaffer, and L Kellaway, and J Taljaard
June 1992, Synapse (New York, N.Y.),
Copied contents to your clipboard!